| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e35b28fa5dd8a6c1efaae96806604835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3748b900663445bbbaf21c33c97db97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e458321178d5a339a8e77042fbddf0e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a901a88edebf37238dcfa315fba6e581 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431 |
| filingDate |
2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfa62737a731fb84b7f664b5322ac0c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17bc8c91167c2544ef2d9d287b3cda65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b143486523a5f030df7e0ddd676e9ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e78bc899f82195f15075699f2c19c8 |
| publicationDate |
2011-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2415671-C1 |
| titleOfInvention |
Method of treating inflammatory complications in patients in ambulatory surgical operations in oral cavity |
| abstract |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to surgical dentistry, and can be applied in treatment of patients with hypo-responsiveness of immune system with inflammatory complications in ambulatory surgical operations in oral cavity. Method includes determination of immune status and introduction of antibiotics, with additional introduction after dental implantation of tamerit in dose 100 mg 2 times per day intramuscularly and in form of daily irrigations of operation area with tamerit solution in dose 100 mg/2 ml during 10 days. ^ EFFECT: invention application ensures increase of treatment efficiency in case of immune system hypo-responsiveness as a result of immune-modulating normobiocenotic and anti-inflammatory action of tamerit. ^ 11 tbl, 4 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623052-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022015198-A1 |
| priorityDate |
2010-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |